THC — Tenet Healthcare Corporation stock price, charts and financials

QT86Tenet Healthcare Corporation

Tenet Healthcare Corporation (NYSE: THC) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
249.99
-4.79-1.88%
THCQT86Tenet Healthcare Corporation·NYSE
249.99-1.88%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E9.75EPS (ttm)26.12Insider Own2.07%Shs Outstand80.52MPerf Week9.25%
Market Cap20.51BForward P/E13.57EPS next Y18.78Insider Trans-4.76%Shs Float82.54MPerf Month33.25%
Enterprise Value31.59BPEG0.15EPS next Q4.22Inst Own-Short Float3.61%Perf Quarter43.85%
Income2.16BP/S0.94EPS this Y-25.98%Inst Trans-Short Ratio2.01Perf Half Y34.46%
Sales21.81BP/B4.57EPS next Y-2.16%ROA7.31%Short Interest2.98MPerf YTD28.21%
Book/sh-P/C5.30EPS next 5Y5.81%ROE50.63%52W High257.75 -3.01%Perf Year58.36%
Cash/sh-P/FCF6.79EPS past 3/5Y59.88% 32.80%ROIC11.91%52W Low153.77 62.57%Perf 3Y231.96%
Dividend Est.-EV/EBITDA6.25Sales past 3/5Y3.58% 3.85%Gross Margin26.87%Volatility4.24% 4.20%Perf 5Y255.69%
Dividend TTM-EV/Sales1.45EPS Y/Y TTM-20.70%Oper. Margin16.80%ATR (14)10.72Perf 10Y716.86%
Dividend Ex-DateMar 13, 2000Quick Ratio1.35Sales Y/Y TTM5.55%Profit Margin10.27%RSI (14)73.60Recom2.19
Dividend Gr. 3/5Y-Current Ratio1.41EPS Q/Q125.69%SMA2018.87%Beta1.22Target Price276.69
Payout0.00%Debt/Eq2.84Sales Q/Q6.77%SMA5032.78%Rel Volume0.74Prev Close254.78
Employees99,000LT Debt/Eq1.46EarningsOct 27SMA20027.14%Avg Volume1.48MPrice249.99
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.130.93% 3.62%Net Debt/EBITDA2.19Volume1,098,221Change-1.88%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedGoldman SachsNeutral$252$305
Jul-28-26ReiteratedRobert W. Baird$210$280
Jul-28-26ReiteratedTruist SecuritiesBuy$270$290
Jul-27-26ReiteratedStephensOverweight$250$285
Jul-27-26ReiteratedPiper Sandler$308
Jul-27-26ReiteratedRaymond JamesOutperform$245$270
Jul-27-26ReiteratedUBSBuy$288$308
Jul-27-26ReiteratedRBC CapitalOutperform$277$283
Jul-27-26ReiteratedMorgan StanleyOverweight$254$274
Jul-24-26ReiteratedBarclaysOverweight$238$271
Latest News
Jul-30-26
Jul-29-26
Jul-28-26
Jul-27-26
Jul-25-26
Jul-24-26
Jul-23-26
Company

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue21,81221,31020,66520,54819,17419,48517,64018,47918,313
Cost of Goods Sold Incl. D&A15,9523,78012,45612,74312,12612,21711,40911,76511,653
Gross Profit5,86017,5308,2097,8057,0487,2686,2316,7146,660
Selling, General and Administrative Excl. Other6,6098,7058,8014184124124033440
Research and Development
000000000
Other Operating Expense-4,4135,386-6,5484,8774,3033,9853,8394,8335,023
Operating Income3,6643,4395,9562,5102,3332,8711,9891,5371,637
Interest Expense8208218269018909231,0039851,004
Unusual Expense
Non-Operating Income (Expense)1,0211821188-98-60-315-232-4
Net Income Before Taxes3,8652,8005,2481,6171,3451,888671320629
Income Taxes6914331,184306344411-97160173
Consolidated Net Income2,2411,4073,200611411914399-215104
Net Income From Continuing Operations3,1742,3674,0641,3111,0011,477768160456
Net Income2,2411,4073,200611411914399-215104
EPS (Recurring)26.1215.6133.026.013.848.553.80-2.241.09
EPS (Basic, Before Extraordinaries)26.1215.6133.026.013.848.553.80-2.241.09
EPS (Diluted)25.9315.4932.705.713.798.423.75-2.241.07
EBITDA5,0584,4846,8923,3883,0763,6662,5312,1552,435
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio9.6412.833.8613.2312.879.7010.6516.02
Price To Sales Ratio0.960.840.590.380.270.450.240.210.10
Gross Margin26.8782.2639.7237.9836.7637.3035.3236.3336.37
Operating Margin16.8016.1428.8212.2212.1714.7311.288.328.94
Net Margin10.276.6015.492.972.144.692.26-1.160.57
Shares Outstanding849097102107107105103102
Market Capitalization20,99917,88512,2447,7085,2218,7414,1933,9171,748
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$279.77$242.64$205.50$168.37$131.24 Close Price0.00M3.76M7.51M11.27M15.03MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Foo Lisa YEVP, Chief Operating OfficerJul 29 '26Sale258.0310,0002,580,30032,053Jul 31
BIERMAN JAMES LDirectorJul 27 '26Sale244.965,0001,224,80031,604Jul 28
Lynch Christopher S.DirectorJul 27 '26Sale243.443,837934,0799,568Jul 28
Arbour Paola MEVP, Chief Information OfficerJul 27 '26Sale243.9010,8782,653,14418,413Jul 28
KERREY J ROBERTDirectorMay 28 '26Sale174.525,638983,92016,804May 29
West NadjaDirectorMay 27 '26Sale177.353,000532,05024,805May 28
KERREY J ROBERTDirectorMay 22 '26Option Exercise0.001,643023,049May 26
BIERMAN JAMES LDirectorMay 22 '26Option Exercise0.001,333036,604May 26
Lynch Christopher S.DirectorMay 22 '26Option Exercise0.001,333013,405May 26
West NadjaDirectorMay 22 '26Option Exercise0.001,333028,298May 26
Romo TammyDirectorMay 22 '26Option Exercise0.001,333036,199May 26
FISHER RICHARD WDirectorMay 22 '26Option Exercise0.001,333010,125May 26
Fitzgerald MeghanDirectorMay 22 '26Option Exercise0.001,333017,580May 26
Agarwala VineetaDirectorMay 22 '26Option Exercise0.001,33304,446May 26
HANEY CECIL DDirectorMay 22 '26Option Exercise0.001,333014,346May 26
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.